Bridging the Gap Between Laboratory Innovation and Industrial Reality
The transition from a successful laboratory pilot to a multi-ton commercial batch is one of the most high-stakes phases in the pharmaceutical lifecycle. A process that works in a 1-liter flask often behaves unpredictably in a 10,000-liter reactor. At Medkem, our Technology Transfer & Scale-Up team specializes in the engineering and scientific rigor required to move your molecule from the bench to the production line without a loss in quality, safety, or yield.
We ensure that your “innovation” becomes a “manufacturable reality.”
Our Comprehensive Scale-Up Framework
Medkem follows a structured, data-driven methodology to ensure that every technology transfer is seamless, documented, and reproducible.
- Process Evaluation & Gap Analysis
Before the transfer begins, we conduct a deep-dive technical audit of the existing lab-scale process.
- Feasibility Assessment:Identifying “choke points” in the current synthesis or formulation that may hinder large-scale production.
- Material Compatibility:Evaluating how raw materials behave in industrial-scale stainless steel or glass-lined reactors (GLRs).
- Equipment Mapping:Matching your laboratory parameters to our specific plant infrastructure (impeller speeds, heating/cooling rates, and filtration capacities).
- Scaling Strategy & Optimization
We don’t just “make it bigger”; we make it better.
- Parameter Optimization:Refining Critical Process Parameters (CPPs) such as temperature, pressure, and agitation to ensure consistent Critical Quality Attributes (CQAs).
- Yield Enhancement:Improving atom economy and solvent recovery to reduce the “Total Cost of Goods” (COGS) at scale.
- Safety & HAZOP Studies:Conducting rigorous Hazard and Operability (HAZOP)studies to identify and mitigate any risks associated with exothermic reactions or hazardous materials during large-scale runs.
- Pilot to Commercial Validation
We manage the “step-up” through dedicated pilot plant trials before full-scale commercialization.
- Kilo-Lab Trials:Validating the process at an intermediate scale to confirm the robustness of the optimized route.
- Process Validation Batches:Producing the mandatory “Three Validation Batches” required by regulatory bodies like the S. FDA to prove the process is consistently reliable.
- Documentation & Knowledge Transfer:Providing exhaustive Technology Transfer Dossiers (TTD) that capture every technical nuance for future regulatory audits.
The Medkem Scale-Up Advantage
- Integrated Engineering & Chemistry:Our team includes both process chemists and chemical engineers, ensuring that the “science” of the molecule aligns perfectly with the “mechanics” of the plant.
- Right-First-Time Approach:Our meticulous planning and simulation models minimize the risk of expensive failed batches during the transition phase.
- Agile Infrastructure:With reactors ranging from 50L (Pilot) to 10,000L (Commercial), we offer a flexible scaling pathway that grows with your market demand.
- Regulatory Readiness:Every scale-up project is conducted in full compliance with cGMP standards, ensuring that the resulting data is ready for inclusion in your DMF or ANDA filings.
Scale with Confidence. Manufacture with Precision.
Don’t let technical hurdles stall your commercial launch. Partner with Medkem’s Technology Transfer team to industrialize your innovation with absolute certainty.